3GS-10330-70646
1 vaccination
1 coded response
14 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 563 / MN
- Registered
- 2022-08-17
- Relationship
- Child or adolescent in my care
- Guardian
- JQ6-11701-31020
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-08-17
Registered in v-safe
-
2022-08-17
Dose 1 — ModernaCo-administered: Do not remember
- 2022-08-17
-
2022-08-18
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Poor · Site: Swelling · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2022-08-19
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Swelling · Muscle or body achesAdult check-in
- 2022-08-20
- 2022-08-21
- 2022-08-22
- 2022-08-23
- 2022-08-24
- 2022-09-07
- 2022-09-14
-
2022-09-21
Survey response — day 35, dose 1, dependentMedDRA: Nasopharyngitis — Feeling: FairFree text: Cold symptoms. She's on day 3 and they seem to be improving.MedDRA releases: 2024-11 · check-in free text available
- 2022-09-28
- 2022-11-18
- 2023-02-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-08-17 | Moderna | Do not remember |
Free text
Release 12 — day 35, dose 1, dependent
Symptoms: Cold symptoms. She's on day 3 and they seem to be improving.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release